Nipro Corporation Competitors and Similar CompaniesClear all

Nipro Corporation's competitors and similar companies include West Pharmaceutical Services, Eisai, Kuraray, Takeda, Astellas Pharma and Nikkiso.
Nipro Corporation
Nipro Corporation
Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging.
West Pharmaceutical Services
West Pharmaceutical Services
West Pharmaceutical Services is a company that manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally.
Eisai
Eisai
Eisai is a research-based human health care company that discovers, develops, packages, and markets pharmaceutical products.
Kuraray
Kuraray
Kuraray (株式会社クラレ) is a company that manufactures chemicals, synthetic and chemical fibers, and other materials.
Takeda
Takeda
Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Astellas Pharma
Astellas Pharma
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
Nikkiso
Nikkiso
Nikkiso (日機装株式会社) is a company that engages in industrial, precision equipment, aerospace, and medical businesses.
Founding Date
Founding Date
1954
Founding Date
1923
Founding Date
1941
Founding Date
1926
Founding Date
1781
Founding Date
1923
Founding Date
1953
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Osaka, JP HQ
Bunkyo City, JP
Kusatsu, JP
Kusatsu, JP
Ohdate, JP
Locations
Exton, US HQ
Munro, AR
Macquarie Park, AU
São Paulo, BR
Shanghai, CN
Shanghai, CN
Tibito, CO
see more
Locations
Bunkyo City, JP HQ
Melbourne, AU
Wien, AT
Leuven, BE
Mississauga, CA
see more
Locations
Chiyoda, JP HQ
Victoria, AU
Beveren, BE
Seneffe, BE
Zwijndrecht, BE
São Paulo, BR
Shanghai, CN
see more
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
Tokyo, JP HQ
Shanghai, CN
Shanghai, CN
Shanghai, CN
Shanghai, CN
Weihai, CN
Hamburg, DE
see more
Employees
Employees
38,770
Employees
10,6001% decrease
Employees
11,076
Employees
11,7033% increase
Employees
49,095
Employees
14,484
Employees
7,629
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
26.2 b
Valuation ($)
12.5 b
Valuation ($)
4.1 b
Valuation ($)
41.7 b
Valuation ($)
17.5 b
Valuation ($)
512.1 m
Twitter followers
Twitter followers
N/A
Twitter followers
2.6 k
Twitter followers
6 k
Twitter followers
919
Twitter followers
N/A
Twitter followers
50.4 k
Twitter followers
30
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
36
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
0.5
Average likes per tweet (last 30 days)
5.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
43.33%
Percentage of tweets with engagement (last 30 days)
97.22%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
96%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
¥442.5b (FY, 2020)
Revenue (est.)
$2.9b (FY, 2023)
Revenue (est.)
¥744.4b (FY, 2023)
Revenue (est.)
¥780.9b (FY, 2023)
Revenue (est.)
¥4t (FY, 2023)
Revenue (est.)
¥1.5t (FY, 2023)
Revenue (est.)
¥192.6b (FY, 2023)
Cost of goods
Cost of goods
¥308.3b (FY, 2020)
Cost of goods
$1.8b (FY, 2023)
Cost of goods
¥137.9b (FY, 2023)
Cost of goods
¥463.8b (FY, 2023)
Cost of goods
¥579.7b (FY, 2023)
Cost of goods
¥182.6b (FY, 2023)
Cost of goods
¥131.2b (FY, 2023)
Gross profit
Gross profit
¥134.2b (FY, 2020)
Gross profit
$1.1b (FY, 2023)
Gross profit
¥614.9b (FY, 2023)
Gross profit
¥317.1b (FY, 2023)
Gross profit
¥3.5t (FY, 2023)
Gross profit
¥1.3t (FY, 2023)
Gross profit
¥62.9b (FY, 2023)
Net income
Net income
(¥11.6b) (FY, 2020)
Net income
$593.4m (FY, 2023)
Net income
¥56.8b (FY, 2023)
Net income
¥42.3b (FY, 2023)
Net income
¥317b (FY, 2023)
Net income
¥98.7b (FY, 2023)
Net income
¥9.1b (FY, 2023)

Operating

Filed Trials Products (Oncology)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
2 (Jul, 2018)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
5 (May, 2021)
Filed Trials Products (Oncology)
N/A
Filed Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
11 (Jul, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
1 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
Phase I/II Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
6 (Jul, 2019)
Phase I/II Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
13 (Jul, 2023)
Phase I/II Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
9 (Jul, 2019)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
1 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
10 (Jul, 2019)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
6 (Jul, 2023)
Phase III Trials Products (Oncology)
4 (Oct, 2020)
Phase III Trials Products (Oncology)
N/A
For sources of this data, please see the company profile

View Company Profiles

West Pharmaceutical Services
HQ
Exton, US
Employees
10,600↓ 1% decrease

West Pharmaceutical Services is a company that manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally.

View company
Eisai
HQ
Bunkyo City, JP
Employees
11,076

Eisai is a research-based human health care company that discovers, develops, packages, and markets pharmaceutical products.

View company
Kuraray
HQ
Chiyoda, JP
Employees
11,703↑ 3% increase

Kuraray (株式会社クラレ) is a company that manufactures chemicals, synthetic and chemical fibers, and other materials.

View company
Takeda
HQ
Tokyo, JP
Employees
49,095

Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company